The tetrapeptide tuftsin effectively impairs the binding of

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

Related Keywords

China , , Image Credit , Ace2 , Coronavirus Disease Covid 19 , Cars , Ars Cov 2 , Antibodies , Binding Affinity , Bioinformatics , Chip , Coronavirus , Covid 19 , Genes , Olecule , Pandemic , Phagocytosis , Eceptor , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Virus ,